Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Gockerman, JP; Silberman, H; Bartolucci, AA

Published Date

  • July 1, 1987

Published In

Volume / Issue

  • 71 / 7-8

Start / End Page

  • 773 - 774

PubMed ID

  • 3300970

Pubmed Central ID

  • 3300970

International Standard Serial Number (ISSN)

  • 0361-5960

Language

  • eng

Conference Location

  • United States